Fukuda Denshi CoFKDSF 83 3-Year ROIIC % is 8.10 as of Mar. 2026, which is 49% below its 10-year median of 15.74. GuruFocus rates FKDSF with a GF Score™ of 83/100 and a GF Value™ of $27.79. The stock has 5 warning signs investors should review. Among 797 Medical Devices & Instruments companies, Fukuda Denshi Co ranks better than 58.97% on this metric.
3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year.
Fukuda Denshi Co's 3-Year ROIIC % for the quarter that ended in Mar. 2026 was 8.10%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for Fukuda Denshi Co's 3-Year ROIIC % or its related term are showing as below:
FKDSF's 3-Year ROIIC % is ranked better than 58.97% of 797
companies
in the Medical Devices & Instruments industry
Industry Median: 1.47
vs FKDSF: 8.10
Fukuda Denshi Co (OTCPK:FKDSF) 3-Year ROIIC % Explanation
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Fukuda Denshi Co 3-Year ROIIC % Related Terms
Fukuda Denshi Co 3-Year ROIIC % Historical Data
* Premium members only.
The historical data trend for Fukuda Denshi Co's 3-Year ROIIC % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Fukuda Denshi Co's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Fukuda Denshi Co 3-Year ROIIC % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Fukuda Denshi Co's 3-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Fukuda Denshi Co's 3-Year ROIIC % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Fukuda Denshi Co (FKDSF) has a 3-Year ROIIC % of 8.10 as of Mar. 2026. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Fukuda Denshi Co and its competitors. This is 49% below median its historical median of 15.74. Over the past decade, Fukuda Denshi Co's 3-Year ROIIC % has ranged from 2.26 to 34.54. According to the industry distribution chart, Fukuda Denshi Co ranks #327 out of 797 companies in the Medical Devices & Instruments industry, placing it in the top 41%.
Is Fukuda Denshi Co's 3-Year ROIIC % too high?
Fukuda Denshi Co's current 3-Year ROIIC % of 8.10 is 49% below median its 10-year median of 15.74. Over the past 10 years, this metric has ranged from a low of 2.26 to a high of 34.54. The Medical Devices & Instruments industry median 3-Year ROIIC % is 1.47. Fukuda Denshi Co's value of 8.10 is 451% above this industry median. Based on the distribution chart, Fukuda Denshi Co ranks #327 out of 797 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Fukuda Denshi Co has a GF Score™ of 83/100, reflecting its overall financial health beyond just this single metric.
How does Fukuda Denshi Co's 3-Year ROIIC % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Fukuda Denshi Co ranks #327 out of 797 companies for 3-Year ROIIC %. This puts Fukuda Denshi Co in the upper half of its industry. The industry median 3-Year ROIIC % is 1.47. Fukuda Denshi Co's value of 8.10 is 451% above this benchmark. Historically, Fukuda Denshi Co's own 3-Year ROIIC % has ranged from 2.26 to 34.54 over the past decade. While the company's 10-year median is 15.74 vs. the industry median of 1.47, Fukuda Denshi Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for a Medical Devices & Instruments company?
The median 3-Year ROIIC % among Medical Devices & Instruments companies is 1.47, based on 797 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Fukuda Denshi Co's current 3-Year ROIIC % of 8.10 is 451% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Fukuda Denshi Co and its competitors. For the Medical Devices & Instruments industry, the median 3-Year ROIIC % is 1.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Fukuda Denshi Co's current 3-Year ROIIC % is 8.10, which is 49% below median its own 10-year median of 15.74. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fukuda Denshi Co stock overvalued right now?
Fukuda Denshi Co (FKDSF) has a current 3-Year ROIIC % of 8.10. The stock's GF Value™ is $27.79, compared to a current price of $42.55 — trading 53.1% above its estimated fair value. The current 3-Year ROIIC % is 8.10, which is 49% below median its 10-year median of 15.74 and 451% above the Medical Devices & Instruments industry median of 1.47. Fukuda Denshi Co's overall GF Score™ is 83/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For Fukuda Denshi Co (FKDSF), the current 3-Year ROIIC % is 8.10 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Fukuda Denshi Co (FKDSF) Overvalued in 2026?
Based on GuruFocus' analysis, Fukuda Denshi Co stock appears to be overvalued.
The current stock price of $42.55 is trading 53.1% above its estimated GF Value™ of $27.79.
Key valuation signals for FKDSF:
3-Year ROIIC %: 8.10 (49% below median its 10-year median of 15.74)
GF Value™: $27.79 vs. price of $42.55 (53.1% above fair value)
Industry Position: 451% above the Medical Devices & Instruments median (#327 of 797)
No single metric tells the full story. See the FKDSF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Fukuda Denshi Co Ltd develops and manufactures medical electronic equipment. The firm operates in four segments: physiological diagnostic equipment, patient monitoring equipment, medical treatment equipment, and consumables and other products. The physiological diagnostic equipment business sells electrocardiographs, vascular screening systems, and blood cell counters. The patient monitoring equipment segment sells patient monitors and transmitters. The medical treatment equipment segment contributes the largest proportion of revenue and sells pacemakers and medical equipment for home treatment. The consumables and other products segment sells disposable electrodes and consumables used for the firm's devices. Fukuda Denshi generates the vast majority of its sales in Japan.
83GF Score
Get the complete analysis for FKDSF
3-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FKDSF has been successfully added to your 
